High concentrations of phenylalanine stimulate peroxisome proliferator-activated receptor γ: Implications for the pathophysiology of phenylketonuria

Neurobiology of Disease

Volumn 32, Issue 3, 2008, Pages 385-390

  Schumacher, Udo ^a   Lukacs, Zoltan ^a   Kaltschmidt, Christian ^b   Freudlsperger, Christian ^a   Schulz, Dorothea ^a   Kompisch, Kai ^a   Müller, Reinhard ^a   Rudolph, Tanja ^a   Santer, René ^a   Lorke, Dietrich E ^a   Ullrich, Kurt ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b BIELEFELD UNIVERSITY   (Germany)

Author keywords

Neuroblastoma cells; Pathophysiology; Peroxisome proliferator activated receptor gamma; Phenylketonuria

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHENYLALANINE;

ARTICLE; CELL CULTURE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CULTURE MEDIUM; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; NEUROBLAST; NEUROBLASTOMA CELL; PATHOPHYSIOLOGY; PHENYLKETONURIA; PRIORITY JOURNAL;

APOPTOSIS; BLOTTING, WESTERN; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; MICROARRAY ANALYSIS; NEUROBLASTOMA; NEURONS; PHENYLALANINE; PHENYLKETONURIAS; PPAR GAMMA; THIAZOLIDINEDIONES;

EID: 56349095797     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2008.07.020     Document Type: Article

References (22)

1. Alvord E.C., Stevendon L.D., Vogel F.S., and Engle R.L. Neuropathological findings in phenylpyruvic oligophrenia (ketonuria). J. Neuropath. Exp. Neurol. 9 (1950) 298-310
2. Ashjian P.-H., Elbarbary A.S., Edmonds B., DeUgarte D., Zhu M., Zuk P.A., Lorenz H.P., Benheim P., and Hedrick M.H. In vitro differentiation of human processed lipoaspirate cells into early neuronal progenitors. Plas. Reconstr. Surg. 111 (2003) 1922-1931
3. Baumann M.L., and Kemper Th.L. Morphologic and histoanatomic observations of the brain in untreated human phenylketonuria. Acta Neuropathol. 58 (1982) 55-63
4. Camp H.S., Li O., Wise S.C., Hong Y.H., Frankowski C.L., Vanbogelen R., and Leff T. Differential activation of peroxisome proliferator-activated receptor-gamma by troglitazone and rosiglitazone. Diabetes 49 (2000) 539-547
5. Fφ{symbol}lling A. Über Ausscheidung von Phenylbrenztraubensäure in den Harn als Stoffwechselanomalie in Verbindung mit Imbezillität. Z. Physiol. Chem. 227 (1934) 169-176
6. Freudlsperger C., Moll I., Schumacher U., and Thies A. Anti-proliferative effect of peroxisome proliferator-activated receptor g agonists on human malignant melanoma cells in vitro. Anti-Cancer Drugs 17 (2006) 325-332
7. Greene L.A., and Tischler A.S. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc. Natl. Acad. Sci. U. S. A. 73 (1976) 2424-2428
8. Hartwig C., Gal A., Santer R., Ullrich K., Finckh U., and Kreienkamp H.-J. Elevated phenylalanine levels interfere with neurite outgrowth stimulated by the neuronal cell adhesion molecule L1 in vitro. FEBS Lett. 580 (2006) 3489-3492
9. Han S., Wada R.K., and Sidell N. Differentiation of human neuroblastoma by phenylacetate is mediated by peroxisome proliferator-activated receptor g. Cancer Res. 61 (2001) 3998-4002
10. Huttenlocher P.R. The neuropathology of phenylketonuria: human and animal studies. Eur. J. Pediatr. 159 Suppl. 2 (2000) S102-S106
11. Kaltschmidt B., Ndiaye D., Korte M., Pothion S., Arbibe L., Prullage M., Pfeiffer J., Lindecke A., Staiger V., Israel A., Kaltschmidt C., and Mehmet S. NF-kappaB regulates spatial memory formation and synaptic plasticity through protein kinase A/CREB signaling. Mol. Cell Biol. 26 (2006) 2936-2946
12. Katoh M., Feldhaus S., Schnitzer T., Bauer S., and Schumacher U. Limited tumor growth (HT29) in vivo under RO205-2349 is due to increased apoptosis and reduced cell volume but not to decreased proliferation rate. Cancer Lett. 210 (2004) 7-15
13. 2+ release signals in NGF-differentiated PC12 cells and hippocampal neurons. Neuron 22 (1999) 125-137
14. Morosetti R., Servidei T., Mirabella M., Rutella S., Mangiola A., Maira G., Mastrangelo R., and Koeffler H.P. The PPARgamma ligands PGJ2 and rosiglitazone show a differential ability to inhibit proliferation and to induce apoptosis and differentiation of human glioblastoma cell lines. Int. J. Oncol. 25 (2004) 493-502
15. Saiki M., Hatta Y., Yamazaki T., Itoh T., Enomoto Y., Takeuchi J., Sawada U., Aizawa S., and Hoie T. Pioglitazone inhibits the growth of human leukaemia cell lines and primary leukemia cells while sparing normal hematopoietic stem cells. Int. J. Oncol. 29 (2006) 437-443
16. Schwamborn J., Lindecke A., Elvers M., Horejschi V., Kerick M., Rafigh M., Pfeiffer J., Prullage M., Kaltschmidt B., and Kaltschmidt C. Microarray analysis of tumor necrosis factor alpha induced gene expression in U373 human glioblastoma cells. BMC Genomics 4 (2003) 46
17. Servidei T., Morosetti R., Gerlini C., Cusano G., Scambia G., Mastrangelo R., and Korffler H.P. The cellular response to PPARgamma ligands is related to the phenotype of neuroblastoma cell lines. Oncol. Res. 14 (2004) 345-354
18. Surendran S., Matalon D., Tyring S.K., Rady P.L., Velagaleti G.V., and Matalon R. Altered expression of myocillin in the brain of a mouse model for phenylketonuria (PKU). Neurosci. Lett. 382 (2005) 323-326
19. Valentiner U., Carlsson M., Erttmann R., Hildebrandt H., and Schumacher U. Ligands for the peroxisome proliferator-activated receptor-gamma have inhibitory effects on growth of human neuroblastoma cells in vitro. Toxicology 213 (2005) 157-168
20. Vamecq J., and Latruffe N. Medical significance of peroxisome proliferators-activated receptors. The Lancet 354 (1999) 141-148
21. Wada K., Nakajima A., Katayama K., Kudo C., Shibuya A., Kubota N., Terauchi Y., Tachibana M., Miyoshi H., Kamisaki Y., Mayumi T., Kadowaki T., and Blumberg R.S. Peroxisome proliferator-activated receptor g-mediated regulation of neural stem cell proliferation and differentiation. J. Biol. Chem. 281 (2006) 12673-12681
22. Williams R.S., Hauser S.L., Purpura D.P., DeLong G.R., and Swisher C.N. Autism and mental retardation. Neuropathologic studies performed in four retarded persons with autistic features. Arch. Neurol. 37 (1980) 749-753